SCHEMBL4036878

SCHEMBL4036878

Cc1cc(-n2cccc2Cl)n[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 5/20 0.35
RAB9A P51151 4/20 0.35
PTPN1 P18031 1/20 0.35
NTRK1 P04629 3/20 0.34
ALK Q9UM73 2/20 0.34
KDM4E B2RXH2 2/20 0.33
GAA P10253 2/20 0.33
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
CCNA1 P78396 1/20 0.33
PDE10A Q9Y233 1/20 0.33
HSD17B10 Q99714 1/20 0.33
DRD3 P35462 2/20 0.32
AURKA O14965 1/20 0.32
SYK P43405 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
CHRM1 P11229 1/20 0.32
DRD1 P21728 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30877258 0.70 L3MBTL1 (0.39) L3MBTL1NPC1RAB9AALKKDM4E
SCHEMBL4759739 0.69 CYP3A4 (0.33) NPC1NTRK1KDM4EGAAHSD17B10
SCHEMBL30822667 0.68 JAK2 (0.39) L3MBTL1NPC1RAB9AALKKDM4E
SCHEMBL30822718 0.66 TYMS (0.39) NPC1RAB9AALKKDM4EGAA
SCHEMBL30822708 0.66 AURKA (0.41) L3MBTL1NPC1RAB9AALKKDM4E
SCHEMBL30822710 0.64 CYP1A2 (0.40) L3MBTL1NPC1RAB9AALKKDM4E
SCHEMBL2113726 0.62 MEN1 (0.45) L3MBTL1NPC1KDM4EGAAHSD17B10
SCHEMBL9040861 0.62 ALDH1A1 (0.41) NPC1RAB9AKDM4EGAAHSD17B10
SCHEMBL12778661 0.61
SCHEMBL1269262 0.61 KDM4E (0.50) L3MBTL1NPC1RAB9AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051980-A1 PYRROLOTRIAZINE KINASE INHIBITORS Brystol-Myers Squibb Company (US) 2009-04-29 EP disclosed
WO-2008021924-A1 PYRROLOTRIAZINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-21 WO disclosed